MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/iid3.70453

Медицинская библиотека · Immunity, inflammation and disease · 2026

Efficacy, Safety and Immunomodulatory Effect of Intramuscular Injections of Autologous Whole Blood Into Acupoints in Patients With Atopic Dermatitis: A Randomized Controlled Trial.

Li Xuan, Zhang Xin-Ru, Lin Ying-Qi, Huang Zhi-Qian, Li Xin-Yan, Yuan Xing-Ru, Liang Shu-Ping, Chen Yong, Wu Ying, Wang Yu-Ling, Zhang Dong-Shu

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

INTRODUCTION

The use of acupoint autohemotherapy (A-AHT) has shown promise in the management of atopic dermatitis (AD); however, the lack of rigorously controlled comparative studies presents a significant obstacle to the establishment of strong clinical evidence.

AIM: We aimed to compare the safety and efficacy of A-AHT and subcutaneous Dupilumab injection in AD patients.

PATIENTS AND

METHODS

Thirty-one patients with moderate-to-severe AD were randomly allocated to receive 8 times of weekly intramuscular autologous whole blood (AWB) injection into bilateral Zusanli (ST36), Xuehai (SP10), Quchi (LI11) and Ashi points (n = 23) or subcutaneous Dupilumab injection with the dosage based on age/weigh (n = 8) for 8 weeks. Changes in SCORAD value, Visual Analog Scale (VAS) scores for pruritus and sleep quality, serum total IgE, cytokines including interleukin (IL)-2, IL-4, IL-6, IL-10, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α levels were assessed at baseline and week 8.

RESULTS

Both treatments resulted in a reduction of SCORAD values and serum IgE levels compared to their baseline (p < 0.001 or p < 0.05); however, no significant differences were observed between the two groups. When compared to the Dupilumab group, A-AHT exhibited greater effectiveness in improving the VAS scores for pruritus and sleep quality. Within the A-AHT group, there was a significant improvement in the serum levels of IL-2, IL-6, IL-10, TNF-α, and IFN-γ at week 8 compared to baseline (p < 0.05 or p < 0.01), whereas no changes were noted in the Dupilumab group. Serious adverse events were not observed.

CONCLUSIONS

A-AHT appears to be effective in treating moderate-to-severe AD, warranting further studies to validate these results.

TRAIL REGISTRATION: ChiCTR2300068163.

Для цитирования: Li Xuan, Zhang Xin-Ru, Lin Ying-Qi, Huang Zhi-Qian, Li Xin-Yan, Yuan Xing-Ru, Liang Shu-Ping, Chen Yong, Wu Ying, Wang Yu-Ling, Zhang Dong-Shu. Efficacy, Safety and Immunomodulatory Effect of Intramuscular Injections of Autologous Whole Blood Into Acupoints in Patients With Atopic Dermatitis: A Randomized Controlled Trial.. Immunity, inflammation and disease. 2026. DOI: 10.1002/iid3.70453.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.